Kadar Homosistein Sebagai Prediktor Derajat Keparahan Pasien Stroke Iskemik Fase Akut

Rosa Zoraya Damanik

Abstract


Tujuan dari penelitian ini adalah  Menganalisis keterkaitan anatara kadar homosistein dan stroke iskemik terutama pada fase akut.. Homosistein yang meningkat kadarnya dalam darah merupakan faktor resiko untuk terjadinya stroke iskemik. Berbagai penelitian juga menyebutkan bahawa kadar homosistein juga berperan dalam prognosis stroke walaupun hal ini masih dianggap kontroversi.Penelitian jenis analitik menggunakan rancangan cross sectional, data diperoleh dari 36 penderita stroke iskemik fase akut rawat inap di RSUP Haji Adam Malik Medan. Kadar homosistein dikelompokkan atas 2 kategori, yaitu kadar homosistein tinggi (>15 μmol/l) normal (≤15 μmol/l). Derajat keparahan Stroke Iskemik Fase Akut diperiksa dengan menggunakan National Institute of Health Stroke Scale (NIHSS).. Kadar homosistein pada pasien objek penelitian (pasien stroke iskemik fase akut)  antara  5 μmol/l - 24,1 μmol/l  (rerata 11,8 μmol/l). Derajat keparahan stroke ringan, yaitu sebanyak 25 orang (69,4%) dan derajat keparahan stroke sedang, yaitu sebanyak 11 orang (30,6%). Hasil uji regresi logistik menunjukkan kadar homosistein berhubungan degan derajat keparahan stroke iskemik fase akut. Artinya pasien stroke iskemik fase akut yang memiliki kadar homosistein tinggi diperkirakan sebagai prediktor meningkatkan risiko keparahan stroke iskemik fase akut sebesar 4,800 kali dibandingkan dengan kadar homosistein normal (p=0,046; OR = 4,800; CI 95%; 1,030-22,370). Kadar homosistein menunjukkan hubungan yang kuat dengan derajat keparahan stroke iskemik fase akut..


Keywords


Homosistein, Prediktor, Stroke iskemik, Fase Akut

Full Text:

PDF

References


ABD, Basim A. Mean platelet volume and its influence on the severity of acute ischemic stroke. Medical Journal of Babylon, 2014, 11.3: 500-506.

Agarwal, Soumya, et al. Study of serum levels of Vitamin B12, folic acid, and homocysteine in vitiligo. Pigment International, 2015, 2.2: 76.

Aminoff MJ, Greenberg DA, Simon RP. Clinical neurology. 6th ed. New York/Toronto: Lange Medical Books, 2005; p. 285-319.

Ashjazadeh, Nahid; Fathi, Morteza; Shariat, Abdohamid. Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes. Iranian journal of medical sciences, 2013, 38.3: 233.

BENJAMIN, Emelia J., et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation, 2017, 135.10: e146-e603.

Biswas, Arijit, et al. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians. Journal of Stroke and Cerebrovascular Diseases, 2009, 18.2: 103-110.

Bogousslavsky J, Lausanne P, Hennerici M.G,. Stroke prevention by the practitioner cerebrovascular disease. 2000: 9, 2-43.

Burhanuddin, Mutmainna, et al. Faktor risiko kejadian stroke pada dewasa awal (18-40 tahun) di kota Makassar tahun 2010-2012. 2013.

Christina BG, Focus On Homocysateine, Springer Verlag Frence, 2001 : 11-79.

Christopher, R., Nagaraja, D., Shankar, S.K.. Homocysteine and cerebral stroke in developing countries. Current Medicinal Chemistry. 2007; 14(22): 2393-2401 [Pubmed]

Clarke S, Banfield K. S-Adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge. Cambridge university press; 2001.p. 63-78.

Depkes RI. Riset Kesehatan Dasar (RISKESDAS) 2007. Lembaga Penerbitan Badan Litbangkes. Jakarta: Departemen Kesehatan Republik Indonesia, 2007

Dierkes, Jutta; Westphal, Sabine. Effect of drugs on homocysteine concentrations. In: Seminars in vascular medicine. Copyright© 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA., 2005. p. 124-139..

Irfan, Muhammad. Fisioterapi bagi insan stroke. Yogyakarta: Graha Ilmu, 2010.

Kalita, Jayantee, et al. Relationship of homocysteine with other risk factors and outcome of ischemic stroke. Clinical neurology and neurosurgery, 2009, 111.4: 364-367.

Kemenkes RI. Riset Kesehatan Dasar (RISKESDAS) 2013. Lembaga Penerbitan Badan Litbangkes. Jakarta, 2013.

Khan, Muhammad Nazim, et al. Serum total and HDL-cholesterol in ischemic and hemorrhagic stroke. Ann. Pak. Inst. Med. Sci, 2014, 10.1: 22-6.

KIM, Anthony S.; Johnston, S. Claiborne. Global variation in the relative burden of stroke and ischemic heart disease. Circulation, 2011, 124.3: 314-323.

Kuller, L. H., et al. Multiple Risk Factor Intervention Trial Research G. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis, 2007, 195: 122-128.

Lingga, Lanny. All About Stroke. Elex Media Komputindo, 2013.

Markišić, Merdin; Pavlović, Aleksandra M.; Pavlović, Dragan M. The impact of homocysteine, vitamin B12, and vitamin D levels on functional outcome after first-ever Ischaemic stroke. BioMed research international, 2017, 2017.

Moran, Andrew, et al. Future cardiovascular disease in China: Markov model and risk factor scenario projections from the coronary heart disease policy model–China. Circulation: Cardiovascular Quality and Outcomes, 2010, 3.3: 243-252.

Okubadejo, Njideka U., et al. Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMC neurology, 2008, 8.1: 26.

Saberi, Alia, et al. Serum homocysteine and the short-term outcome of ischemic stroke. Journal of Neurology Research, 2014, 4.1: 15-21.

Sjahrir H. Stroke Iskemik. Yandira Agung, Medan, 2003, 1-3.

Soeharto, Iman. Serangan jantung dan stroke hubungannya dengan lemak & kolestrol. 2nd ed. Jakarta: PT Gramedia Pustaka Utama, 2004.

Sudianto, Rut Pamela. Hubungan Kadar Hemoglobin dengan Prognosis pada Pasien Stroke Iskemik di RSUD Dr. Moewardi. 2015.

Tan, Nigel Choon-Kiat, et al. Hyperhomocyst (e) inemia and risk of ischemic stroke among young Asian adults. Stroke, 2002, 33.8: 1956-1962.

Venkata Madhav, M., Anjaneya Prasad, V. and Pradeep Babu, K.V. Homocysteine as an Independent Risk Factor for Cerebral Ischemic Stroke in South Indian Population in Rural Tertiary Care Centre. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 6, Issue 5 (May.- Jun. 2013), PP 49-53.

Widyayanto, Isnawan. Hubungan Antara Kadar Homosistein Serum Fase Akut dengan Kemandirian Fungsional Jangka Pendek Pasien Stroke Iskemik. Medica Hospitalia-Journal Of Clinical Medicine, 2017, 3.1.

World Health Organization (WHO). WHO STEPS Stroke Manual: the WHO STEPwise approach to stroke surveillance. Geneva: World Health Organization; 2006. 4-6.

Yaseen, Zainab, et al. “Prognostic Significance of Plasma Homocysteine and Malondialdehyde in Patients with Acute Ischemic Stroke.” International Journal of Pharma Research and Health Sciences, 2015, 3. 727-736

Yudawijaya, Agus; Kustiowati, Endang; Pemayun, Tjokorda Gde Dalem. Homosistein plasma dan perubahan skor fungsi kognitif pada pasien pasca stroke iskemik. Media Medika Indonesiana, 2011, 45.1: 8-15.




DOI: https://doi.org/10.30743/best.v6i1.6804

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

 

https://scholar.google.co.id/citations?user=kvKzX3QAAAAJ&hl=id&authuser=4

Best Journal (Biology Education, Sains and Technology)

Program Studi Pendidikan Biologi, FKIP - Universitas Islam Sumatera Utara
Kampus Induk UISU Jl. Sisingamangaraja XII Teladan, Medan

Creative Commons License